Studies have shown that XBJ mainly inhibits the activation of inflammatory pathways by inhibiting TNF-α, IL-1, IL-6, IL-8, IL-17 and PAR-1 and improves coagulation dysfunction in sepsis [27–29]. This evidence concerns the gene IL17A and Sepsis.